420 related articles for article (PubMed ID: 31578566)
1. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the DiversiLab system.
Dou HT; Xu YC; Wang HZ; Li TS
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):753-62. PubMed ID: 25471194
[TBL] [Abstract][Full Text] [Related]
6. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil.
de Holanda Fonseca DL; Silva DMWD; de Albuquerque Maranhão FC
Braz J Microbiol; 2024 Jun; 55(2):1369-1380. PubMed ID: 38619732
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
Nyazika TK; Hagen F; Meis JF; Robertson VJ
J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
[TBL] [Abstract][Full Text] [Related]
10. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
11. Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.
Mihara T; Izumikawa K; Kakeya H; Ngamskulrungroj P; Umeyama T; Takazono T; Tashiro M; Nakamura S; Imamura Y; Miyazaki T; Ohno H; Yamamoto Y; Yanagihara K; Miyzaki Y; Kohno S
Med Mycol; 2013 Apr; 51(3):252-60. PubMed ID: 22901045
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea.
Choi YH; Ngamskulrungroj P; Varma A; Sionov E; Hwang SM; Carriconde F; Meyer W; Litvintseva AP; Lee WG; Shin JH; Kim EC; Lee KW; Choi TY; Lee YS; Kwon-Chung KJ
FEMS Yeast Res; 2010 Sep; 10(6):769-78. PubMed ID: 20561059
[TBL] [Abstract][Full Text] [Related]
14. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
Feng X; Yao Z; Ren D; Liao W; Wu J
FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.
Lahiri Mukhopadhyay S; Bahubali VH; Manjunath N; Swaminathan A; Maji S; Palaniappan M; Parthasarathy S; Chandrashekar N
Mycoses; 2017 Nov; 60(11):749-757. PubMed ID: 28736880
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans/Cryptococcus gattii species complex in southern Italy: an overview on the environmental diffusion of serotypes, genotypes and mating-types.
Romeo O; Scordino F; Chillemi V; Criseo G
Mycopathologia; 2012 Oct; 174(4):283-91. PubMed ID: 22531979
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.
Kassi FK; Drakulovski P; Bellet V; Krasteva D; Gatchitch F; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Mallié M; Menan HIE; Bertout S
Mycoses; 2016 Dec; 59(12):811-817. PubMed ID: 27461533
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]